An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease.
Yang ZhangJian-Xing LuoYan-Ge LiHong-Fang FuFang YangXiao-Yu HuPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
GLS has a significant hepatoprotective effect on NAFLD patients, causing a decrease in FGF-21 secretion in response to the damage itself.